United States
Securities and Exchange Commission
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
|
Filed by the Registrant ☒
|
|
|
|
|
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary
Proxy Statement
☐
Confidential,
for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
☐
Definitive
Proxy Statement
☒
Definitive
Additional Materials
☐
Soliciting Material under §240.14a-12
DERMATA THERAPEUTICS, INC.
(Name of Registrant as Specified in its
Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the
Registrant)
Payment of Filing Fee (Check all boxes that apply):
☐
Fee
paid previously with preliminary materials
☐
Fee
computed on table in exhibit required by Item 25(b) per Exchange
Act Rules 14a-6(i)(1) and 0-11
|
DERMATA THERAPEUTICS, INC.
|
CONTROL ID:
|
|
|
REQUEST ID:
|
|
|
|
|
IMPORTANT NOTICE
REGARDING THE AVAILABILITY OF PROXY MATERIALSfor the Annual Meeting of
Stockholders
|
|
|
DATE:
|
Monday, July 11, 2022
|
|
|
TIME:
|
9:00 A.M. pacific time
|
|
|
LOCATION:
|
https://agm.issuerdirect.com/drma
|
|
|
|
|
|
HOW TO REQUEST PAPER COPIES OF OUR MATERIALS
|
|
|
|
|
|
|
PHONE:
Call toll free
1-866-752-8683
|
FAX:
Send this card to
202-521-3464
|
INTERNET:
https://www.iproxydirect.com/drma
and follow the on-screen
instructions.
|
EMAIL:
proxy@iproxydirect.com
Include your Control ID in your
email.
|
|
|
|
This communication represents a notice
to access a more complete set of proxy materials available to you
on the Internet. We encourage you to access and review all of the
important information contained in the proxy materials before
voting. The proxy statement is available at: https://www.iproxydirect.com/drma
|
|
|
|
If you want to receive a paper copy of the proxy materials you must
request one. There is no charge to you for requesting a copy. To
facilitate timely delivery please make the request, as instructed
above, before June 20, 2022.
|
|
|
|
|
|
you may enter your voting instructions
at https://www.iproxydirect.com/drma
until 11:59 pm eastern time July 10,
2022.
|
|
|
|
The purposes of this meeting are as follows:
|
|
|
1. To
elect two director nominees to serve as directors until the 2025
annual meeting of stockholders;
2. To
ratify the appointment of Mayer Hoffman McCann P.C. as our
independent registered public accounting firm for the year ending
December 31, 2022;
3. To
approve an amendment to our Amended and Restated Certificate of
Incorporation to increase the Company’s authorized shares of
common stock from 90,000,000 to 250,000,000; and
4. To
consider any other matters that may properly come before the Annual
Meeting.
|
|
|
Pursuant to Securities and Exchange Commission rules, you are
receiving this Notice that the proxy materials for the Annual
Meeting are available on the Internet. Follow the instructions
above to view the materials and vote or request printed
copies.
The board of directors has fixed the close of business on May12,
2022 as the record date for the determination of stockholders
entitled to receive notice of the Annual Meeting and to vote the
shares of our common stock and preferred stock, they held on that
date at the meeting or any postponement or adjournment of the
meeting.
|
|
The Board of Directors recommends that you vote ‘for’
all proposals above.
|
|
|
|
Please note - This is not a Proxy Card - you cannot vote by
returning this card
|
Dermata Therapeutics, Inc.
SHAREHOLDER
SERVICES
1
Glenwood Avenue Suite 1001
Raleigh
NC 27603
TIME SENSITIVE SHAREHOLDER INFORMATION ENCLOSED
IMPORTANT SHAREHOLDER INFORMATION
YOUR VOTE IS IMPORTANT
